Curative Biotechnology Inc (CUBT)

[Wrangler1]

“The Company also requests in accordance with Rule 457(p) of the Act that all fees paid to the Commission in connection with the filing of the Registration Statement be credited for future use.” This comment in the RW today lends credence to your assumption that it ain’t over. I don’t think they have come this far to not get it done. Negotiations take time, particularly given this is an OTC Pink sheet company trying to get to a major exchange.

Under Rule 457(p), the filing fees from unsold securities may be carried over to offset filing fees for a subsequent offering. I don’t think they would make this comment if they were throwing in the towel.